Thursday, September 3, 2015  
United States
United Kingdom
skip to the main content area of this page
Skip Navigation Links
Clinical Development
Study Startup
Clinical Monitoring
Data Management
Global Safety
Medical Writing
Clinical Supply Distribution
Other Study Services

Our Contact Information

Mailing ::
4365 Route 1 South
Princeton, NJ 08540

Click for Directions
Phone 609.799.7580
Fax 609.799.4148

Clinical Development Services
  • Clinical Development Strategy Consulting
  • Regulatory Strategy Consulting
  • Pre-clinical Toxicology and Pharmacology Review
  • Preparation of non-U.S. Regulatory Filing to National Health Authorities
  • Preparation of IND Filings
  • Negotiation of Resolution of FDA Questions
  • Develop Assessment Techniques for Drug and Diagnostic/Prognostic Antibody Tests
Study Startup Services
  • Investigator / Site Selection
  • Case Report Form Design
  • Protocol Writing
  • Study Manual Design
  • Regulatory Document Collection
Clinical Monitoring Services
  • Clinical Monitoring by Staff Specially Trained in Oncology Clinical Trial Monitoring
  • Performance of GCP Compliance Audits
  • Clinical Trials Integrity Auditing
  • Selection and Administration of Quality of Life and Pharmacoeconomic Instruments
Analysis Services Global Safety Services
  • Global Safety Reporting and Medical Review
  • Preparation of SAE Narratives and Summaries
  • Support and Coordination of Data Safety Monitoring Boards (DSMB)
Medical Writing Services
  • Preparation of Annual and Final Clinical Study Reports
  • Preparation of Abstracts and Manuscripts
Clinical Supply Distribution Services
  • Investigational Drug Storage and Distribution
Other Study Coordination Services
  • Coordination and Presentation at Investigator Meetings
  • Randomization Services via Interactive Voice Response System (IVRS), Therand®
  • Secure Limited Access Status Reporting via TheraGuard®
To accommodate your individual needs, Please contact us for further details and related information.

Theradex® has over 27 years of oncology clinical trials experience with an emphasis on Phase I studies. Since our founding in 1982, we have monitored and held the data for all US National Cancer Institute Phase I trials.

Theradex® has supported both broad and target Phase II programs for our clients. From single center two-stage design to multinational randomized Phase II programs. Theradex has the in-house expertise to support your research program.

Theradex® has successfully managed international Phase III programs supporting the development of cytotoxics, biologics and molecular targeted therapies.